Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
05/2005
05/25/2005EP0946511B1 Novel compounds with analgesic effect
05/25/2005DE10352082A1 Hexylcarboxanilide Hexylcarboxanilides
05/25/2005DE10352067A1 Isopentylcarboxanilide Isopentylcarboxanilide
05/25/2005DE10349502A1 1,3-Dimethylbutylcarboxanilide 1,3-Dimethylbutylcarboxanilide
05/25/2005CN1620439A Pancreatic lipase inhibitor compounds, their synthesis and use
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/24/2005US6897331 Fluorous triphase and other multiphase systems
05/24/2005US6897240 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use
05/24/2005US6897237 MMP-12 inhibitors
05/24/2005US6897220 Antiproliferative agents
05/19/2005WO2005044870A1 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and process for preparing polyolefins
05/19/2005WO2005044810A1 Glyt2 modulators
05/19/2005WO2005044008A2 2 -aminothiophene compounds as fungicides
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2005028429A3 Haloalkyl containing compounds as cysteine protease inhibitors
05/19/2005WO2005016868A3 Matrix metalloproteinase inhibitors
05/19/2005US20050107621 Catalytic reduction with ruthenium/diphenylethylenediamine derivative; amidation, deesterification
05/19/2005US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors
05/19/2005US20050107448 Calcium receptor antagonists
05/19/2005US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/19/2005US20050107397 Sulfonamide derivatives as d3-receptor agonists
05/19/2005US20050107389 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
05/19/2005US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide
05/19/2005US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders
05/19/2005US20050107334 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
05/19/2005US20050106502 Information recording medium and oxonol compound
05/19/2005US20050106414 9,9-Dimethylfluorene trimers capped with aromatic amine groups used to produce an organic light-emitting device that exhibits an extremely pure luminescent hue and has a light emission of high efficiency, high brightness, and long lifetime
05/19/2005DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/18/2005EP1531155A1 Asymmetrical linear organic oligomers
05/18/2005EP1531154A2 Process for the preparation of linear organic thiophene/phenylene oligomers
05/18/2005EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation
05/18/2005EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
05/18/2005EP1530470A1 Selective estrogen receptor modulators containing a phenylsulfonyl group
05/18/2005EP1301502B1 Compounds and their use as glycine transport inhibitors
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005CN1617868A Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1616454A Preparation of thiophene monomer and its polymerizing method
05/18/2005CN1616453A Antivirally active heterocyclic azahexane derivatives
05/18/2005CN1616452A 维生素d类似物 Vitamin d analogues
05/18/2005CN1616451A Process for the purification of thiophenes
05/18/2005CN1616446A Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring
05/18/2005CN1616417A Photo-stable cosmetic and pharmaceutical formulations containing UV-filters
05/18/2005CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/18/2005CN1202203C Dye adulterated organic-inorganic hybridized material
05/18/2005CN1202093C Substituted heterocyclic compound
05/17/2005US6894064 Benzothiophenes, formulations containing same, and methods
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/17/2005CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042494A1 Isopentyl carboxanilides for combating undesired micro-organisms
05/12/2005WO2005042493A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
05/12/2005WO2005042492A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
05/12/2005WO2005042478A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/12/2005WO2005007635A8 Combretastatin derivatives with cytotoxic action
05/12/2005WO2004087061B1 Tubulin binding agents and corresponding prodrug constructs
05/12/2005WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005US20050101787 Reaction of metal complex and nitrogen compound to form nitro or nitrile complex
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/12/2005US20050101663 Synthetic lactone formulations and method of use
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050100805 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus
05/12/2005US20050098777 Process for the production of linear organic thiophene-phenylene oligomers
05/12/2005DE10392370T5 Verfahren zur Herstellung einer Carbonylverbindung A process for producing a carbonyl compound
05/12/2005CA2543054A1 Isopentylcarboxanilides for combating undesired micro-organisms
05/12/2005CA2540881A1 Thieno-pyridinone derivatives as kinase inhibitors
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2539446A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/12/2005CA2487210A1 Asymmetrical linear organic oligomers
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1084711B1 Remedies for the treatment of itching containing pgd2 antagonists
05/11/2005EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
05/11/2005EP0945450B1 Fused heterocyclic benzenecarboxylic acid amide derivatives and pgd2 antagonists containing the same
05/11/2005EP0861071B1 Benzamidoxime prodrugs and use thereof for treating pneumonia
05/11/2005EP0854915B1 Cd23 cleavage enzyme preparation
05/11/2005CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
05/11/2005CN1615305A Coumarin derivatives, process for their production and use thereof
05/11/2005CN1613853A PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof
05/11/2005CN1200935C Method for preparing benzofuran or benzothiophene compound
05/10/2005US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors
05/10/2005US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1
05/06/2005WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications
05/06/2005WO2005040138A1 Substituted benzylaminoalkylene heterocycles
05/06/2005WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
05/06/2005WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto
05/06/2005WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005WO2005040095A1 Inhibitors of dipeptidyl peptidase iv
05/06/2005WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
05/06/2005WO2004002939A3 Aminoalcohol derivatives
05/06/2005CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005CA2542695A1 Substituted benzylaminoalkylene heterocycles
05/06/2005CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
05/05/2005US20050096477 Astaxanthin esters
05/05/2005US20050096476 Lily of the valley aromachemicals
05/05/2005US20050096404 Formed from mesogen such as 2,7-bis{5-[4-(8-diallylaminooctyloxy)phenyl]-thien-2-yl}-9,9-dipropylfluorene; photopolymerization without photoinitiator; lowcost, bright, portable displays; simple manufacturing, enhanced power and transmission efficiency; does not require polarizer
05/05/2005US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections